Bioresponsive immune-booster-based prodrug nanogel for cancer immunotherapy

The combination of chemotherapy and immunotherapy motivates a potent immune system by triggering immunogenic cell death (ICD), showing great potential in inhibiting tumor growth and improving the immunosuppressive tumor microenvironment (ITM). However, the therapeutic effectiveness has been restrict...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Xianbin, Yang, Shaochen, Zhang, Tian, Wang, Shuo, Yang, Qichao, Xiao, Yao, Shi, Xiaoxiao, Xue, Peng, Kang, Yuejun, Liu, Gang, Sun, Zhi-Jun, Xu, Zhigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800001/
https://www.ncbi.nlm.nih.gov/pubmed/35127398
http://dx.doi.org/10.1016/j.apsb.2021.05.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800001/
https://www.ncbi.nlm.nih.gov/pubmed/35127398
http://dx.doi.org/10.1016/j.apsb.2021.05.016

Ejemplares similares